Resonance Specialties Limited (BOM:524218)

Market Cap	1.29B
Revenue (ttm)	778.07M
Net Income (ttm)	65.66M
Shares Out	11.54M
EPS (ttm)	5.65
PE Ratio	19.79
Forward PE	n/a
Dividend	1.00 (0.94%)
Ex-Dividend Date	Jul 29, 2025

Volume	142,742
Average Volume	37,886
Open	90.05
Previous Close	88.48
Day's Range	89.55 - 106.17
52-Week Range	65.00 - 117.50
Beta	0.55
RSI	75.36
Earnings Date	May 14, 2025

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 68
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In 2024, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.